Journal of Clinical Medicine (Feb 2023)

Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience

  • Cary A. Presant,
  • Kimlin Ashing,
  • Dan Raz,
  • Sophia Yeung,
  • Brenda Gascon,
  • Alexis Stewart,
  • Jonjon Macalintal,
  • Argelia Sandoval,
  • Loretta Ehrunmwunsee,
  • Tanyanika Phillips,
  • Ravi Salgia,
  • Amartej Merla,
  • Shanmuga Subbiah,
  • Michelle El-Hajjouie,
  • Jeffrey Staley,
  • Heather Graves,
  • Ranjan Pathak,
  • Shaira Dingal,
  • Sagus Sampath,
  • Beverly Laksana,
  • Thomas Joseph,
  • Tricia Eugenio,
  • Veronica Degoma,
  • Kathleen Burns,
  • Sarah Phillips,
  • Tingting Tan,
  • Kelly Tarkshian,
  • Virginia Sun,
  • Arya Amini,
  • Khristie Davy,
  • Janet Cronkhite,
  • Mary Cianfrocca,
  • Susan Brown,
  • Yuman Fong,
  • Steven Rosen

DOI
https://doi.org/10.3390/jcm12041275
Journal volume & issue
Vol. 12, no. 4
p. 1275

Abstract

Read online

Background: Tobacco control is important for cancer patient health, but delivering effective low-dose CT (LDCT) screening and tobacco cessation is more difficult in underserved and patients from racial and ethnic minority groups. At City of Hope (COH), we have developed strategies to overcome barriers to the delivery of LDCT and tobacco cessation. Methods: We performed a needs assessment. New tobacco control program services were implemented focusing on patients from racial and ethnic minority groups. Innovations included Whole Person Care with motivational counseling, placing clinician and nurse champions at points of care, training module and leadership newsletters, and a patient-centric personalized medicine Personalized Pathways to Success (PPS) program. Results: Emphasis on patients from racial and ethnic minority groups was implemented by training cessation personnel and lung cancer control champions. LDCT increased. Tobacco use assessment increased and abstinence was 27.2%. The PPS pilot program achieved 47% engagement in cessation, with self-reported abstinence at 3 months of 38%, with both results slightly higher in patients from racial and ethnic minority groups than in Caucasian patients. Conclusions: Tobacco cessation barrier-focused innovations can result in increased lung cancer screening and tobacco cessation reach and effectiveness, especially among patients from racial and ethnic minority groups. The PPS program is promising as a personalized medicine patient-centric approach to cessation and lung cancer screening.

Keywords